Literature DB >> 34352206

N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression.

Zihao Dai1, Haining Liu1, Junbin Liao1, Cheng Huang2, Xiaoxue Ren3, Wanjie Zhu3, Shenghua Zhu3, Baogang Peng1, Shaoqiang Li1, Jiaming Lai4, Lijian Liang1, Lixia Xu5, Sui Peng6, Shuibin Lin7, Ming Kuang8.   

Abstract

Cancer cells selectively promote translation of specific oncogenic transcripts to facilitate cancer survival and progression, but the underlying mechanisms are poorly understood. Here, we find that N7-methylguanosine (m7G) tRNA modification and its methyltransferase complex components, METTL1 and WDR4, are significantly upregulated in intrahepatic cholangiocarcinoma (ICC) and associated with poor prognosis. We further reveal the critical role of METTL1/WDR4 in promoting ICC cell survival and progression using loss- and gain-of-function assays in vitro and in vivo. Mechanistically, m7G tRNA modification selectively regulates the translation of oncogenic transcripts, including cell-cycle and epidermal growth factor receptor (EGFR) pathway genes, in m7G-tRNA-decoded codon-frequency-dependent mechanisms. Moreover, using overexpression and knockout mouse models, we demonstrate the crucial oncogenic function of Mettl1-mediated m7G tRNA modification in promoting ICC tumorigenesis and progression in vivo. Our study uncovers the important physiological function and mechanism of METTL1-mediated m7G tRNA modification in the regulation of oncogenic mRNA translation and cancer progression.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34352206     DOI: 10.1016/j.molcel.2021.07.003

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  42 in total

1.  N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/β-catenin pathway in nasopharyngeal carcinoma.

Authors:  Binbin Chen; Wei Jiang; Ying Huang; Jian Zhang; Peng Yu; Lirong Wu; Hao Peng
Journal:  Oncogene       Date:  2022-02-26       Impact factor: 9.867

2.  N6-methyladenosine (m6A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation.

Authors:  Hao Peng; Binbin Chen; Wei Wei; Siyao Guo; Hui Han; Chunlong Yang; Jieyi Ma; Lu Wang; Sui Peng; Ming Kuang; Shuibin Lin
Journal:  Nat Metab       Date:  2022-08-23

Review 3.  METTLing in Stem Cell and Cancer Biology.

Authors:  John G Tooley; James P Catlin; Christine E Schaner Tooley
Journal:  Stem Cell Rev Rep       Date:  2022-09-12       Impact factor: 6.692

Review 4.  tRNA dysregulation and disease.

Authors:  Esteban A Orellana; Elisabeth Siegal; Richard I Gregory
Journal:  Nat Rev Genet       Date:  2022-06-09       Impact factor: 59.581

5.  [m7G-lncRNAs are potential biomarkers for prognosis and tumor microenvironment in patients with colon cancer].

Authors:  S Chen; R Dong; Y Li; H Wu; M Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

Review 6.  The Key Role of RNA Modification in Breast Cancer.

Authors:  Yang Liu; Tong Zhu; Yi Jiang; Jiawen Bu; Xudong Zhu; Xi Gu
Journal:  Front Cell Dev Biol       Date:  2022-06-01

7.  Expression and Potential Biomarkers of Regulators for M7G RNA Modification in Gliomas.

Authors:  Zhen Chen; Zhe Zhang; Wei Ding; Jie-Hui Zhang; Zi-Long Tan; Yu-Ran Mei; Wei He; Xiao-Jing Wang
Journal:  Front Neurol       Date:  2022-05-09       Impact factor: 4.086

Review 8.  EpisomiR, a New Family of miRNAs, and Its Possible Roles in Human Diseases.

Authors:  Yasuko Arao; Mika Nakayama; Yoshiko Tsuji; Yumiko Hamano; Chihiro Otsuka; Andrea Vecchione; Ken Ofusa; Hideshi Ishii
Journal:  Biomedicines       Date:  2022-05-30

9.  Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma.

Authors:  Chuanhao Zhang; Dong Zhou; Zhe Wang; Zaishuang Ju; Jiabei He; Genghao Zhao; Ruoyu Wang
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

Review 10.  Modifications of the human tRNA anticodon loop and their associations with genetic diseases.

Authors:  Jing-Bo Zhou; En-Duo Wang; Xiao-Long Zhou
Journal:  Cell Mol Life Sci       Date:  2021-10-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.